The latest price target for Labcorp Holdings (NYSE:LH) was reported by UBS on January 28, 2025. The analyst firm set a price target for $286.00 expecting LH to rise to within 12 months (a possible 14.49% upside). 30 analyst firms have reported ratings in the last year.

The latest analyst rating for Labcorp Holdings (NYSE:LH) was provided by UBS, and Labcorp Holdings maintained their buy rating.

The last upgrade for Labcorp Holdings Inc happened on January 7, 2025 when Evercore ISI Group raised their price target to $265. Evercore ISI Group previously had an in-line for Labcorp Holdings Inc.

The last downgrade for Labcorp Holdings Inc happened on December 12, 2022 when Citigroup changed their price target from N/A to $250 for Labcorp Holdings Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Labcorp Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Labcorp Holdings was filed on January 28, 2025 so you should expect the next rating to be made available sometime around January 28, 2026.

While ratings are subjective and will change, the latest Labcorp Holdings (LH) rating was a maintained with a price target of $293.00 to $286.00. The current price Labcorp Holdings (LH) is trading at is $249.80, which is out of the analyst’s predicted range.